Registry of Cardiovascular Disease Patients
- Conditions
- Ischemic Heart DiseaseCongestive Heart FailurePeripheral Vascular DiseaseCerebrovascular DiseaseAtrial FibrillationCerebrovascular Atherosclerosis
- Registration Number
- NCT01759225
- Lead Sponsor
- Maccabi Healthcare Services, Israel
- Brief Summary
A computerized registry of cardiovascular disease patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify cardiovascular disease patients and to follow the courses of their illnesses and risk factors.
- Detailed Description
The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution.
The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 110000
- Clinical Diagnosis of the following:
Ischemic Heart Disease,MI,non-MI,congestive heart failure,peripheral vascular disease, cerebrovascular disease CVA,TIA,patients with first AMI diagnosis from community physicians if they were hospitalized for lasting at least 3 days during a 30-day period prior to diagnosis.
- Patients with prior coronary artery bypass grafting(CABG) or percutaneous coronary intervention (PCI), using relevant Current Procedural Terminology (CPT) codes
- patients who were diagnosed as suffering from CHD by primary physician or general hospitals prior to 2000 with no further indication
- Patients whose primary physician reported that the patient is CHD-free providing adequate medical records
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of Patients with Cardiovascular disease Up to 100 years
- Secondary Outcome Measures
Name Time Method prevalence rates of CVD up to 100 years Major Adverse Cardiac Events up to 100 years Number of LDL Tests performed reaching target LDL up to 100 years Proportion of dyslipidemia patients treated with Statins up to 100 years
Trial Locations
- Locations (1)
Maccabi Healthcare Services
🇮🇱Tel Aviv, Israel